These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 18594166

  • 1. [Serum free light chains for diagnosis and follow-up of multiple myeloma].
    Jung S, Kim M, Lim J, Kim Y, Han K, Min CK, Min WS.
    Korean J Lab Med; 2008 Jun; 28(3):169-73. PubMed ID: 18594166
    [Abstract] [Full Text] [Related]

  • 2. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY, Suh JT, Lee HJ, Yoon HJ, Lee WI.
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [Abstract] [Full Text] [Related]

  • 3. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation.
    Dogaru M, Lazăr V, Coriu D.
    Roum Arch Microbiol Immunol; 2011 Sep; 70(1):15-22. PubMed ID: 21717807
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
    Hutchison CA, Plant T, Drayson M, Cockwell P, Kountouri M, Basnayake K, Harding S, Bradwell AR, Mead G.
    BMC Nephrol; 2008 Sep 22; 9():11. PubMed ID: 18808676
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic performance of serum free light chain measurement in patients suspected of a monoclonal B-cell disorder.
    Vermeersch P, Van Hoovels L, Delforge M, Mariën G, Bossuyt X.
    Br J Haematol; 2008 Nov 22; 143(4):496-502. PubMed ID: 18729849
    [Abstract] [Full Text] [Related]

  • 7. [Clinical usefulness of serum free light chain measurement in monoclonal gammopathy].
    Shimazaki C, Murakami H, Sawamura M, Matsuda M, Kinoshita T, Hata H, Sugiura I, Tsushita K, Nagura E, Kosugi H, Itoh J, Shimizu K.
    Rinsho Ketsueki; 2010 Apr 22; 51(4):245-52. PubMed ID: 20467220
    [Abstract] [Full Text] [Related]

  • 8. Bortezomib in combination with conventional chemotherapeutic agents for multiple myeloma compared with bortezomib alone.
    Min CK, Lee MJ, Eom KS, Lee S, Lee JW, Min WS, Kim CC, Kim M, Lim J, Kim Y, Han K.
    Jpn J Clin Oncol; 2007 Dec 22; 37(12):961-8. PubMed ID: 18156171
    [Abstract] [Full Text] [Related]

  • 9. Atypical imaging feature of non-secretory multiple myeloma.
    Neeravari A, Netravati P, Mohammed R, Ragupathi AR, Nagarajappa AH.
    Ann Diagn Pathol; 2011 Aug 22; 15(4):268-72. PubMed ID: 21546295
    [Abstract] [Full Text] [Related]

  • 10. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis.
    Jaskowski TD, Litwin CM, Hill HR.
    Clin Vaccine Immunol; 2006 Feb 22; 13(2):277-80. PubMed ID: 16467338
    [Abstract] [Full Text] [Related]

  • 11. Serum free light chains for monitoring multiple myeloma.
    Mead GP, Carr-Smith HD, Drayson MT, Morgan GJ, Child JA, Bradwell AR.
    Br J Haematol; 2004 Aug 22; 126(3):348-54. PubMed ID: 15257706
    [Abstract] [Full Text] [Related]

  • 12. Serum free light chain analysis may miss monoclonal light chains that urine immunofixation electrophoreses would detect.
    Shaheen SP, Levinson SS.
    Clin Chim Acta; 2009 Aug 22; 406(1-2):162-6. PubMed ID: 19410572
    [Abstract] [Full Text] [Related]

  • 13. Complementarily of urine analysis and serum free light chain assay for assessing response treatment response: illustrated by three case examples.
    Levinson SS.
    Clin Chim Acta; 2011 Nov 20; 412(23-24):2206-10. PubMed ID: 21864518
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the serum free light chain (sFLC) analysis in prediction of response in symptomatic multiple myeloma patients: rapid profound reduction in involved FLC predicts achievement of VGPR.
    Hansen CT, Pedersen PT, Nielsen LC, Abildgaard N.
    Eur J Haematol; 2014 Nov 20; 93(5):407-13. PubMed ID: 24809596
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
    Shimizu K, Itoh J, Sugiura I, Tsushita K, Kosugi H, Nagura E.
    Rinsho Ketsueki; 2006 Apr 20; 47(4):303-9. PubMed ID: 16715965
    [Abstract] [Full Text] [Related]

  • 16. Heavy/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients.
    Beaumont-Epinette MP, Moreau C, Besnard S, Latute F, Collet N, Sebillot M, Grosbois B, Bendavid C, Guenet L, Decaux O.
    Pathol Biol (Paris); 2015 Sep 20; 63(4-5):215-21. PubMed ID: 26319969
    [Abstract] [Full Text] [Related]

  • 17. The evolving use of serum free light chain assays in haematology.
    Pratt G.
    Br J Haematol; 2008 May 20; 141(4):413-22. PubMed ID: 18318757
    [Abstract] [Full Text] [Related]

  • 18. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
    Ščudla V, Lochman P, Pika T, Zapletalová J, Minařík J, Bačovský J.
    Cas Lek Cesk; 2015 May 20; 154(6):292-302. PubMed ID: 26750626
    [Abstract] [Full Text] [Related]

  • 19. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.
    Campbell JP, Cobbold M, Wang Y, Goodall M, Bonney SL, Chamba A, Birtwistle J, Plant T, Afzal Z, Jefferis R, Drayson MT.
    J Immunol Methods; 2013 May 31; 391(1-2):1-13. PubMed ID: 23388695
    [Abstract] [Full Text] [Related]

  • 20. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
    Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R, Palumbo A, Jagannath S, Blade J, Lonial S, Dimopoulos M, Comenzo R, Einsele H, Barlogie B, Anderson K, Gertz M, Harousseau JL, Attal M, Tosi P, Sonneveld P, Boccadoro M, Morgan G, Richardson P, Sezer O, Mateos MV, Cavo M, Joshua D, Turesson I, Chen W, Shimizu K, Powles R, Rajkumar SV, Durie BG, International Myeloma Working Group.
    Leukemia; 2009 Feb 31; 23(2):215-24. PubMed ID: 19020545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.